Cite
Long-term outcome of unresectable metastatic colorectal cancer (MCRC) patients (pts) treated with first-line folfoxiri followed by r0 surgical resection of metastases
MLA
Gianluca Masi, et al. Long-Term Outcome of Unresectable Metastatic Colorectal Cancer (MCRC) Patients (Pts) Treated with First-Line Folfoxiri Followed by R0 Surgical Resection of Metastases. Jan. 2007. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..bedd8576abdbe28854e50d3fe42d9eaa&authtype=sso&custid=ns315887.
APA
Gianluca Masi, Bursi, S., Loupakis, F., Barletta, M., Barbara, C., Vasile, E., Cupini, S., Brunetti, I., Pfanner, E., Di Donato, S., Dauria, G., Fanchini, L., Chiara, S., Granetto, C., & Alfredo Falcone. (2007). Long-term outcome of unresectable metastatic colorectal cancer (MCRC) patients (pts) treated with first-line folfoxiri followed by r0 surgical resection of metastases.
Chicago
Gianluca Masi, S. Bursi, F. Loupakis, M. Barletta, C. Barbara, E. Vasile, S. Cupini, et al. 2007. “Long-Term Outcome of Unresectable Metastatic Colorectal Cancer (MCRC) Patients (Pts) Treated with First-Line Folfoxiri Followed by R0 Surgical Resection of Metastases,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..bedd8576abdbe28854e50d3fe42d9eaa&authtype=sso&custid=ns315887.